Cisplatin-associated nephrotoxicity and pathological events

Contrib Nephrol. 2005;148:107-121. doi: 10.1159/000086055.

Abstract

Cisplatin (cis-diamminedichloroplatinum(II)) is an effective chemotherapeutic agent, and is successfully used in the treatment of a wide range of tumors. Despite its effectiveness as an anti-tumor drug, nephrotoxic side effects have significantly restricted its clinical use. Tubular epithelial cell deletion following cisplatin treatment is a major cause of renal injury. Oxidative stress significantly contributes to cisplatin-associated cytotoxicity, and use of antioxidants could counteract such cytotoxic effects of cisplatin. The renal microenvironmental changes following cisplatin treatment is a complex process and could be broadly categorized into three main pathological events, which at times might overlap: initial cytotoxic events, inflammatory events and fibroproliferative events. Stress responses and heat shock proteins generated following cisplatin treatment are actively involved in the initiation and progression of these events. In this article, we will briefly summarize factors involved in various phases of cisplatin-induced renal injuries.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cisplatin / adverse effects*
  • Heat-Shock Proteins / metabolism*
  • Humans
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / metabolism
  • Kidney Diseases / pathology
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Heat-Shock Proteins
  • Cisplatin